Clinical Trial Update: Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 multi-center trial evaluating whether simvastatin reduces hepatic decompensation and death in high-risk compensated cirrhosis; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Cirrhosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING